The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Jun. 07, 2016
Applicant:

Epizyme, Inc., Cambridge, MA (US);

Inventors:

Edward J. Olhava, Newton, MA (US);

Richard Chesworth, Concord, MA (US);

Roy M. Pollock, Medford, MA (US);

Lei Jin, Wellesley, MA (US);

Assignee:

Epizyme, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 19/16 (2006.01); C07H 19/14 (2006.01); G06F 19/16 (2011.01); C40B 30/02 (2006.01); A61K 31/708 (2006.01); A61K 31/7064 (2006.01); A61K 31/7068 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01);
U.S. Cl.
CPC ...
C07H 19/16 (2013.01); C07H 19/14 (2013.01); C40B 30/02 (2013.01); G06F 19/16 (2013.01); A61K 31/708 (2013.01); A61K 31/7064 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01);
Abstract

The present invention relates to DOT1L inhibitors and methods of identifying, designing, or optimizing them. The present invention also relates to crystals of DOT1L-inhibitor complexes, the crystal structures thereof, and the use of the crystal structures. Also disclosed are pharmaceutical compositions containing these DOT1L inhibitors and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof.


Find Patent Forward Citations

Loading…